Diehl V, Georgii A: Lymphocyte-predominant Hodgkin's Disease: An immunhistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol 1997; 150(3): 793-803 [...] R, Hansmann ML, Hübner K, Franklin K, Tesch H, Paulus U, Werner M, Diehl V, Georgii A: Classical Hodgkin's disease. Clinical impact of immunophenotype. Am J Pathol 1997; 151(4): 1123-30 von Wasielewski

H, Haedicke C, Dühmke E, Georgii A, Loeffler M: BEACOPP: A new regimen for advanced Hodgkin's disease German Hodgkin Lymphoma Study Group. Ann Oncol 1998; 9 (Suppl 5): 67-71 Diehl V, Franklin J, Hasenclever [...] at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's lymphoma Study Group. J Clin Oncol 1998; 16(12): 3810-21 Duensing [...] NL, Kadin ME, MacLennan KA, Poppema S, Stein H, Weiss LE, Müller-Hermelink HK: Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann Oncol 1998; 9(Suppl 5): 31-8 Schnittger

Hepatitis Leberzirrhose Glomerulonephritis Diabetische Glomerulopathie Magenulcus Akute Appendizitis Hodgkin-Lymphom Sarkoidose Morbus Basedow Seborrhoische Keratose Naevuszellnaevus Basalzellkarzinom Malignes [...] Osteomyelitis im Kiefer Riesenzellepulis Odontoameloblastom Ameloblastisches Fibrom Ameloblastom Non-Hodgkin-Lymphom Kaposi-Sarkom Leukoplakie Plattenepithelkarzinom, gut differenziert Plattenepithelkarzinom

D, Schlen S, Brosmann O, Hasenclever D, Wilkowski R, Becker K: Randomized trial with early stage Hodgkin's disease testing 30 gy vs 40 gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys [...] Nietgen G, Wilkens L, Georgii A: Detection of numerical karyotype changes in the giant cells of Hodgkin's lymphomas by a combination of FISH and immunohistochemistry applied to paraffin sections. Histochem [...] Nolte M, Werner M, Georgii A: Light-chain mRNA in lymphocyte-predominant and in mixed-cellularity Hodgkin's disease. Mod Pathol 1996; 9(3): 334-8 Weimann A, Klempnauer J, Gebel M, Maschek H, Bartels M, Ringe

5 Jahre als Studienärztin der multizentrischen Therapiestudie der GPOH zur Therapie maligner Non-Hodgkin-Lymphome des Kindesalters (NHL-BFM) tätig. In dieser Zeit wurde ihr wissenschaftliches Interesse

(Abscopal Effect of Radiotherapy and Nivolumab in anti-PDl Pretreated Relapsed or Refractory classical Hodgkin Lymphoma) – internationale multizentrische Phase II Studie Biomarker-Studie (Molekulare Grundlagen

Allrounder-Qualitäten gefragt waren. Ich war an Projekten wie der ersten Studienzentrale der Deutschen Hodgkin-Studiengruppe, dem „MEDKOM“-Videokonferenznetz, der Redaktion der „Onkologischen Mitteilungen für

inhibitor–induced autoimmune central nervous system disorder in patients with metastatic melanoma and Hodgkin’s lymphoma. Clin Exp Neuroimmunol. 2021;12:127-134. Erlmeier F , Steffens S , Stöhr S, Herrmann E

2891-900 Klein R, Mullges W, Bendszus M, Woydt M, Roggendorf W, Kreipe H: Primary intracerebral Hodgkin's disease: report of case with Epstein-Barr virus association and review of the literature. Am J

V, Georgii A: Tissue Eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin’s disease, allowing for known prognostic factors. Blood 2000; 95(4): 1207-13 Weber I, Fritz C, Ruttowski